title: Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery.
abstract: OBJECTIVE
  The aim of this study was to compare short-term results obtained with transanal total mesorectal excision (TME) and laparoscopic surgery.
  
  
  BACKGROUND
  Transanal TME appears as an alternative in the treatment of rectal cancer and other rectal disease. Natural orifices transluminal endoscopic surgery using the rectum as access in colorectal surgery is intuitively better suited than other access routes.
  
  
  METHODS
  All consecutive patients with middle or low rectal cancer submitted to surgery were included into a prospective cohort and treated by transanal TME assisted by laparoscopy. They were compared with a retrospective cohort of consecutive patients of identical characteristics treated by laparoscopic TME in the immediate chronological period.
  
  
  RESULTS
  Thirty-seven patients were included in both study groups. No differences were observed between them with respect to baseline characteristics, thus emphasizing the comparability of both cohorts. Surgical time was higher in the laparoscopy group (252 ± 50 minutes) than in the transanal group (215 ± 60 minutes) (P < 0.01). Moreover, coloanal anastomosis was performed less frequently (16% vs 43%, respectively; P = 0.01) and distal margin was lower (1.8 ± 1.2 mm vs 2.7 ± 1.7 mm, respectively; P = 0.05) in the laparoscopy group than in the transanal one. Although there was no significant difference in 30-day postoperative complication rate (laparoscopy, 51% vs transanal, 32%; P = 0.16), early readmissions were more frequent in the laparoscopy group than in the transanal one (22% vs 6%, respectively; P = 0.03).
  
  
  CONCLUSIONS
  Evaluation of short-term outcomes demonstrated that transanal TME is a feasible and safe technique associated with a shorter surgical time and a lower early readmission rate.
authors.affiliation: Departments of *Gastrointestinal Surgery †Gastroenterology, Institute of Digestive and Metabolic Diseases, Hospital Clinic, IDIBAPS*, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), University of Barcelona, Centro Esther Koplowitz, and Cellex Biomedical Research Centre, Barcelona, Catalonia, Spain.
authors.forename: María
authors.initials: M
authors.lastname: Fernández-Hevia
authors.forename: Salvadora
authors.initials: S
authors.lastname: Delgado
authors.forename: Antoni
authors.initials: A
authors.lastname: Castells
authors.forename: Marta
authors.initials: M
authors.lastname: Tasende
authors.forename: Dulce
authors.initials: D
authors.lastname: Momblan
authors.forename: Gabriel
authors.initials: G
authors.lastname: Díaz del Gobbo
authors.forename: Borja
authors.initials: B
authors.lastname: DeLacy
authors.forename: Jaume
authors.initials: J
authors.lastname: Balust
authors.forename: Antonio M
authors.initials: AM
authors.lastname: Lacy
mesh_terms: D000230:Adenocarcinoma / Q000601:surgery*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001003:Anal Canal; D005260:Female; D006801:Humans; D010535:Laparoscopy; D008297:Male; D008875:Middle Aged; D057605:Natural Orifice Endoscopic Surgery / Q000379:methods*; D061646:Operative Time; D010359:Patient Readmission / Q000706:statistics & numerical data; D011183:Postoperative Complications / Q000453:epidemiology; D011446:Prospective Studies; D012004:Rectal Neoplasms / Q000601:surgery*; D012007:Rectum / Q000601:surgery*; D012189:Retrospective Studies; D016896:Treatment Outcome